
Adolf D. Berhane
Examiner (ID: 2145, Phone: (571)272-2077 , Office: P/2838 )
| Most Active Art Unit | 2838 |
| Art Unit(s) | 2102, 2111, 2722, 2838, 2899 |
| Total Applications | 4100 |
| Issued Applications | 3647 |
| Pending Applications | 180 |
| Abandoned Applications | 306 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6600265
[patent_doc_number] => 20100292295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => '5-OXO-3-PYRROLIDINECARBOXAMIDE DERIVATIVES AS P2X7 MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 12/808017
[patent_app_country] => US
[patent_app_date] => 2008-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10090
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292295.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808017
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808017 | 5-OXO-3-PYRROLIDINECARBOXAMIDE DERIVATIVES AS P2X7 MODULATORS | Dec 16, 2008 | Abandoned |
Array
(
[id] => 6055832
[patent_doc_number] => 20110112192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'VERFAHREN ZUR GERUCHSEXTINKTION'
[patent_app_type] => utility
[patent_app_number] => 12/808011
[patent_app_country] => US
[patent_app_date] => 2008-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1712
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20110112192.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808011
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808011 | VERFAHREN ZUR GERUCHSEXTINKTION | Dec 10, 2008 | Abandoned |
Array
(
[id] => 7550752
[patent_doc_number] => 08063085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-22
[patent_title] => 'Substituted hydantoins'
[patent_app_type] => utility
[patent_app_number] => 12/331538
[patent_app_country] => US
[patent_app_date] => 2008-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30387
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/063/08063085.pdf
[firstpage_image] =>[orig_patent_app_number] => 12331538
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/331538 | Substituted hydantoins | Dec 9, 2008 | Issued |
Array
(
[id] => 6445909
[patent_doc_number] => 20100144737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'METHODS FOR INHIBITING T HELPER CELL DIFFERENTIATION'
[patent_app_type] => utility
[patent_app_number] => 12/316028
[patent_app_country] => US
[patent_app_date] => 2008-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 25340
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144737.pdf
[firstpage_image] =>[orig_patent_app_number] => 12316028
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/316028 | METHODS FOR INHIBITING T HELPER CELL DIFFERENTIATION | Dec 7, 2008 | Abandoned |
Array
(
[id] => 5343317
[patent_doc_number] => 20090181967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'New compounds I'
[patent_app_type] => utility
[patent_app_number] => 12/315698
[patent_app_country] => US
[patent_app_date] => 2008-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22489
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181967.pdf
[firstpage_image] =>[orig_patent_app_number] => 12315698
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/315698 | Compounds I | Dec 4, 2008 | Issued |
Array
(
[id] => 5480738
[patent_doc_number] => 20090203695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Compounds IV'
[patent_app_type] => utility
[patent_app_number] => 12/315830
[patent_app_country] => US
[patent_app_date] => 2008-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8964
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203695.pdf
[firstpage_image] =>[orig_patent_app_number] => 12315830
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/315830 | Compounds IV | Dec 4, 2008 | Abandoned |
Array
(
[id] => 5380488
[patent_doc_number] => 20090192327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'METHODS AND COMPOSITIONS FOR INHIBITING BIOFILMS'
[patent_app_type] => utility
[patent_app_number] => 12/327349
[patent_app_country] => US
[patent_app_date] => 2008-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7537
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20090192327.pdf
[firstpage_image] =>[orig_patent_app_number] => 12327349
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/327349 | METHODS AND COMPOSITIONS FOR INHIBITING BIOFILMS | Dec 2, 2008 | Abandoned |
Array
(
[id] => 8421848
[patent_doc_number] => 08278336
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-02
[patent_title] => 'Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/743013
[patent_app_country] => US
[patent_app_date] => 2008-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26420
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12743013
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/743013 | Compounds | Nov 20, 2008 | Issued |
Array
(
[id] => 6598431
[patent_doc_number] => 20100048706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Ethoxylated and/or Hydrogenated Oil Adduct'
[patent_app_type] => utility
[patent_app_number] => 12/528889
[patent_app_country] => US
[patent_app_date] => 2008-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7923
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048706.pdf
[firstpage_image] =>[orig_patent_app_number] => 12528889
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/528889 | Ethoxylated and/or Hydrogenated Oil Adduct | Nov 19, 2008 | Abandoned |
Array
(
[id] => 5355571
[patent_doc_number] => 20090186915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'Compositions and methods for treatment of glioblastoma, gliosarcoma, NSCLC, and head and neck cancer'
[patent_app_type] => utility
[patent_app_number] => 12/313187
[patent_app_country] => US
[patent_app_date] => 2008-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 28377
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186915.pdf
[firstpage_image] =>[orig_patent_app_number] => 12313187
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/313187 | Compositions and methods for treatment of glioblastoma, gliosarcoma, NSCLC, and head and neck cancer | Nov 16, 2008 | Abandoned |
Array
(
[id] => 5533119
[patent_doc_number] => 20090232907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Compositions and methods for treatment of esophageal cancer'
[patent_app_type] => utility
[patent_app_number] => 12/313179
[patent_app_country] => US
[patent_app_date] => 2008-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 27538
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232907.pdf
[firstpage_image] =>[orig_patent_app_number] => 12313179
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/313179 | Compositions and methods for treatment of esophageal cancer | Nov 16, 2008 | Abandoned |
Array
(
[id] => 5539823
[patent_doc_number] => 20090221628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Compositions and methods for treatment of prostate and breast cancer'
[patent_app_type] => utility
[patent_app_number] => 12/313186
[patent_app_country] => US
[patent_app_date] => 2008-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 27851
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221628.pdf
[firstpage_image] =>[orig_patent_app_number] => 12313186
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/313186 | Compositions and methods for treatment of prostate and breast cancer | Nov 16, 2008 | Abandoned |
Array
(
[id] => 6276141
[patent_doc_number] => 20100256181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/742159
[patent_app_country] => US
[patent_app_date] => 2008-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45113
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256181.pdf
[firstpage_image] =>[orig_patent_app_number] => 12742159
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/742159 | Non-nucleoside reverse transcriptase inhibitors | Nov 13, 2008 | Issued |
Array
(
[id] => 5265573
[patent_doc_number] => 20090118258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'COMBINATION THERAPY COMPRISING ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND VASOPRESSIN RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/265098
[patent_app_country] => US
[patent_app_date] => 2008-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9179
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118258.pdf
[firstpage_image] =>[orig_patent_app_number] => 12265098
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/265098 | COMBINATION THERAPY COMPRISING ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND VASOPRESSIN RECEPTOR ANTAGONISTS | Nov 4, 2008 | Abandoned |
Array
(
[id] => 6267709
[patent_doc_number] => 20100298402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'STILBENE DERIVATIVES AS PSTAT3/IL-6 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/734484
[patent_app_country] => US
[patent_app_date] => 2008-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16914
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298402.pdf
[firstpage_image] =>[orig_patent_app_number] => 12734484
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/734484 | STILBENE DERIVATIVES AS PSTAT3/IL-6 INHIBITORS | Nov 3, 2008 | Abandoned |
Array
(
[id] => 8533429
[patent_doc_number] => 08309583
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-13
[patent_title] => 'Desferrioxamine conjugates, derivatives and analogues'
[patent_app_type] => utility
[patent_app_number] => 12/740957
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 8739
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12740957
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/740957 | Desferrioxamine conjugates, derivatives and analogues | Oct 30, 2008 | Issued |
Array
(
[id] => 5507958
[patent_doc_number] => 20090081165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'BICYCLIC HETEROARYL DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/262093
[patent_app_country] => US
[patent_app_date] => 2008-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86673
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081165.pdf
[firstpage_image] =>[orig_patent_app_number] => 12262093
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/262093 | BICYCLIC HETEROARYL DERIVATIVES | Oct 29, 2008 | Abandoned |
Array
(
[id] => 5576062
[patent_doc_number] => 20090143424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'TETRAKIS-QUATERNARY AMMONIUM SALTS AND METHODS FOR MODULATING NEURONAL NICOTINIC ACTEYLCHOLINE RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 12/260502
[patent_app_country] => US
[patent_app_date] => 2008-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15606
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143424.pdf
[firstpage_image] =>[orig_patent_app_number] => 12260502
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/260502 | Tetrakis-quaternary ammonium salts and methods for modulating neuronal nicotinic acteylcholine receptors | Oct 28, 2008 | Issued |
Array
(
[id] => 5452327
[patent_doc_number] => 20090068364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'Method of surface treatment using imidazole compound'
[patent_app_type] => utility
[patent_app_number] => 12/290328
[patent_app_country] => US
[patent_app_date] => 2008-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2135
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20090068364.pdf
[firstpage_image] =>[orig_patent_app_number] => 12290328
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/290328 | Method of surface treatment using imidazole compound | Oct 28, 2008 | Issued |
Array
(
[id] => 4480
[patent_doc_number] => 07816391
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-19
[patent_title] => 'Chemical compounds'
[patent_app_type] => utility
[patent_app_number] => 12/259562
[patent_app_country] => US
[patent_app_date] => 2008-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44810
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/816/07816391.pdf
[firstpage_image] =>[orig_patent_app_number] => 12259562
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/259562 | Chemical compounds | Oct 27, 2008 | Issued |